Abstract:Objective To study the effect of stereotactic brain puncture in the treatment of hypertensive deep brain hemorrhage. Methods A total of 78 cases of hypertensive patients with hypertensive deep brain hemorrhage in Nanchang 334 Hospital from January 2017 to January 2020 were selected and randomly divided into control group (n=39) and test group (n=39). The control group received medical conservative treatment, and the test group received stereotactic intracranial hematoma aspiration. The operation-related indicators, preoperative and 3 months postoperative neurological function, postoperative serum C-reactive protein (CRP) and postoperative complications were compared between the two groups. Results The operation and hospitalization time of the experimental group was shorter than that of the control group, the hospitalization cost was less than that of the control group, and the hematoma clearance rate was higher than that of the control group, the differences were statistically significant (P<0.05). At 3 months after surgery, the Guslago coma scores(GCS)and the Guslago prognosis scores(GOS)of the two groups were higher than those before the operation,and the test group was higher than the control group, the differences were statistically significant (P <0.05). The incidence of postoperative complications in the experimental group was lower than that in the control group, and the difference was statistically significant (P<0.05). The postoperative serum CRP level of the experimental group was lower than that of the control group, and the difference was statistically significant (P <0.05). Conclusion Stereotactic craniopuncture can effectively improve the hematoma clearance rate, improve the neurological function, reduce the serum CRP level, reduce the inflammatory reaction, and promote the postoperative recovery of patients with hypertensive deep brain hemorrhage.
罗云辉 . 脑立体定向锥颅穿刺治疗高血压脑深部中量出血的效果研究[J]. 中国当代医药, 2021, 28(30): 52-54转57.
LUO Yun-hui. Study on the effect of stereotactic brain puncture in the treatment of hypertensive deep brain hemorrhage. 中国当代医药, 2021, 28(30): 52-54转57.